14th May 2003 - Board Minutes
Minutes of the Board Meeting held on Wednesday 14th May, 2003 at 2.00pm Boardroom, National Blood Centre, Jamess Street, Dublin 8
Present:
Mr Michael McLoone (Chairman)
Mr Tony McNamara
Dr Mary Horgan
Dr Gerry Crotty
Ms Valerie Mannix
Dr Karen Murphy
Dr Cees Van Der Poel
Ms Maura McGrath
Dr Anne OConnor
Apologies:
Dr Helen Enright
Dr Liz Keane
In Attendance:
Mr Andrew Kelly (A/CEO)
Dr William Murphy (NMD)
Mr Michael Healy (SEO)
1. Minutes of Meeting 09.04.2003
The minutes of the Board meeting held on Wednesday April 9th, 2003 were adopted on the proposal of Dr. Mary Horgan, seconded by Ms. V. Mannix and signed by the Chairman.
2. Matters arising
Progesa
The Progesa system went live in Dublin on May 6th, 2003 and the Chairman thanked the Acting CEO for his extensive work input to bring this about.
Netherlands Blood Transfusion Service
Dr. van der Poel gave a presentation to the Board on the blood service in the Netherlands. The Chairman thanked Dr. van der Poel for his presentation and suggested that some further detail on the Dutch experience of new structures, roles and responsibilities might inform the organisation development process within the IBTS. Dr. van der Poel agreed to provide this detail to the National Medical Director and the Acting CEO in the coming weeks.
3. Correspondence
Tendering process for Recombinant Products
The Acting CEO briefed the Board on correspondence received from some member of the Product Selection Group and it was agreed that the correspondence should be followed up with a meeting with Ms. M. Jackson, Department of Health and Children, and the relevant members of the Product Selection Group.
It was noted that Mr. P. Farrell had tendered his resignation from the Board, due to heavy work commitments. It was agreed that Ms. M. McGrath would replace Mr. Farrell as the second signatory on the Seal of the Board.
It was also noted that Dr. M. Horgan, Mr. T. McNamara and Dr. K. Murphy term on the Board would finish on 31st May 2003. In the event that Mr. T. McNamara was not re-appointed, Dr. A. OConnor agreed to serve on the Finance Committee in his place. The Chairman, on behalf of the Board, thanked the outgoing members for their service on the Board and noted his personal appreciation for their support for him as Chairman of the Board.
The Board noted the correspondence from Deputy B. OKeeffe regarding the possibility of NAT testing at St. Finbarrs Hospital. It was agreed that Mr. A. Kelly would contact Mr. S. Hurley of the SHB on the matter.
The Board approved the inclusion of Dr. A. OConnor as a trustee of the IBTS pension scheme.
4. CEO Report
The report was noted.
Progesa
The Acting CEO briefed the Board on the current situation with regard to Progesa, which is now live in Dublin and Cork. The Board noted the importance of implementing Progesa go live and fully endorsed the rationale of the Acting CEO in his actions for implementing go live. The Board approved the once off settlement with Team Leaders and certain staff in Donor Services and IT regarding the implementation of Progesa go live.
It was noted that there were a number of cost savings with the implementation of Progesa with regard the maintenance of the BBCS system and ongoing consultancy fees.
It was noted that the IT manager, Mr. A. Corrigan and IT staff had worked extremely hard to bring about Progesa go live in Cork and Dublin.
5. Donor Study Update
6. Organisation Development & Change
7. Minutes of MAC meeting 12th March 2003
Dr. M. Horgan briefed the Board on the MAC meeting of 12th March 2003. It was noted that the West Nile Virus deferral was implemented on May 6th, 2003.
8. Minutes of Finance Committee 9th April 2003
Ms. V. Mannix briefed the Board on the meeting of the Finance Committee of 9th April 2003. It was noted that the role of Internal Auditor will be carried out by a person on contract for the moment.
It was agreed that the Terms of Reference of the Audit Committee and Finance Committee would be reviewed, to ensure compliance with the Code of Practice on Corporate Governance of State Bodies and would be signed off at the next Board meeting.
The Finance Committee agreed to formally establish a procedure whereby the system of internal financial control would be reviewed on an annual basis and signed off by the Board. It was agreed that the Statement on the system of internal financial control in the IBTS for year-end 31st December 2003 would be signed off at the June Board meeting.
9. Filling of post of Chief Executive
The Chairman circulated a report to the Board on the recruitment of the Chief Executive. The report set out a summary of the recruitment and selection process from initial assessment, preliminary interviews, the assessment techniques and final interview. The outcome of the final interview was that
. was recommended for the position of Chief Executive subject to satisfactory references on performance and character.
10. Date of next meeting
The next meeting of the Board of the IBTS will take place on Wednesday 11th June 2003 at 2.00 p.m. at the National Blood Centre.
Signed: .. Date: .
